Tekla Capital Management LLC Global Blood Therapeutics, Inc. Transaction History

Tekla Capital Management LLC

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Feb 12, 2021	SELL	$37.65 - $63.77 $2.7 Million - $4.58 Million	-71,759 Closed	0 $0
Q2 2020 Aug 13, 2020	SELL	$48.73 - $81.82 $2.26 Million - $3.79 Million	-46,324 Reduced 39.23%	71,759 $4.53 Million
Q1 2020 May 14, 2020	SELL	$41.72 - $87.2 $1.21 Million - $2.54 Million	-29,085 Reduced 19.76%	118,083 $6.03 Million
Q4 2019 Feb 13, 2020	BUY	$45.7 - $81.86 $2.48 Million - $4.44 Million	54,211 Added 58.32%	147,168 $11.7 Million
Q3 2019 Nov 13, 2019	BUY	$45.35 - $57.91 $1.15 Million - $1.47 Million	25,441 Added 37.68%	92,957 $4.51 Million
Q2 2019 Aug 14, 2019	SELL	$52.6 - $63.29 $971,627 - $1.17 Million	-18,472 Reduced 21.48%	67,516 $3.55 Million
Q1 2019 May 14, 2019	SELL	$39.99 - $53.48 $317,360 - $424,417	-7,936 Reduced 8.45%	85,988 $4.55 Million
Q4 2018 Feb 13, 2019	SELL	$31.54 - $46.67 $1.21 Million - $1.79 Million	-38,346 Reduced 28.99%	93,924 $3.86 Million
Q3 2018 Nov 13, 2018	BUY	$38.0 - $51.1 $2.77 Million - $3.72 Million	72,880 Added 122.71%	132,270 $5.03 Million
Q2 2018 Aug 13, 2018	SELL	$38.7 - $50.15 $2.73 Million - $3.54 Million	-70,558 Reduced 54.3%	59,390 $2.68 Million
Q4 2017 Feb 14, 2018	BUY	$29.7 - $45.7 $2 Million - $3.08 Million	67,448 Added 107.92%	129,948 $5.11 Million
Q3 2017 Nov 13, 2017	SELL	$25.1 - $31.05 $1.57 Million - $1.94 Million	-62,500 Reduced 50.0%	62,500 $1.94 Million
Q2 2017 Aug 14, 2017	BUY	N/A	125,000	125,000 $3.42 Million

288K

Ticker GBT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 67,476,200
Market Cap $4.62B
Description
Global Blood Therapeutics, Inc., a biopharmaceutical company, engages in the discovery, development, and delivery of treatments for underserved patient communities with sickle cell disease (SCD). The company offers Oxbryta tablets, an oral, once-daily therapy for SCD. It also evaluates the safety and pharmacokinetics of single and multiple doses...

Get notified when there are updates to the investment portfolio of Tekla Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Tekla Capital Management LLC with notifications on news.